Showing results (6781-6790 of 10,083) with videos related to
Sort By:
Pageof 1,009
Current Pharmaceutical Design|July 30, 2013
Human imprinting anomalies in fetal and childhood growth disorders: clinical implications and molecular mechanismsSalah Azzi, Fréderic Brioude, Yves Le Bouc, et al.Current Pharmaceutical Design|July 30, 2013
A family of pleiotropically acting microRNAs in cancer progression, miR-200: potential cancer therapeutic targetsHai-Feng Zhang, Li-Yan Xu, En-Min LiCurrent Pharmaceutical Design|July 30, 2013
Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cellsInês Graça, Elsa J Sousa, Tiago Baptista, et al.Current Pharmaceutical Design|July 30, 2013
Evidence for epigenetic alterations in Turner syndrome opens up feasibility of new pharmaceutical interventionsShriram N Rajpathak, Deepti D DeobagkarCurrent Pharmaceutical Design|December 7, 2013
A Perspective on Rational Designs of a Hemagglutinin Based Universal Influenza VaccineThanh D Van, Nhut Tran, Ly Le, et al.Current Pharmaceutical Design|December 30, 2011
Gene therapy targeting inflammation in atherosclerosisTim Van-Assche, Veronique Huygelen, Mark J Crabtree, et al.Current Pharmaceutical Design|December 30, 2011
Circular micro-proteins and mechanisms of cyclizationBrendon F Conlan, Marilyn A AndersonCurrent Pharmaceutical Design|December 30, 2011
Crotamine, a small basic polypeptide myotoxin from rattlesnake venom with cell-penetrating propertiesGandhi Rádis-Baptista, Irina KerkisCurrent Pharmaceutical Design|January 4, 2012
Fermented grape marc (FGM): immunomodulating properties and its potential exploitation in the treatment of neurodegenerative diseasesG Marzulli, T Magrone, K Kawaguchi, et al.Pageof 1,009